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Abstract
In the striatum, cholinergic interneurons (CINs) have the ability to release both acetylcholine and glutamate, due to the expression of the vesicular acetylcholine transporter (VAChT) and the vesicular glutamate transporter 3 (VGLUT3). However, the
relationship these neurotransmitters have in the regulation of behavior is not fully
understood. Here we used reward-based touchscreen tests in mice to assess the individual and combined contributions of acetylcholine/glutamate co-transmission
in behavior. We found that reduced levels of the VAChT from CINs negatively
impacted dopamine signalling in response to reward, and disrupted complex responses in a sequential chain of events. In contrast, diminished VGLUT3 levels had
somewhat opposite effects. When mutant mice were treated with haloperidol in a
cue-based task, the drug did not affect the performance of VAChT mutant mice,
whereas VGLUT3 mutant mice were highly sensitive to haloperidol. In mice where
both vesicular transporters were deleted from CINs, we observed altered reward-
evoked dopaminergic signalling and behavioral deficits that resemble, but were

Abbreviations: Ach, acetylcholine; ANOVA, two-way analysis of variance; ChAT, choline acetyl-transferase; CIN, cholinergic interneurons; D2,
dopamine receptor 2; FR, fixed ratio; GFP, green fluorescent protein; Glu, glutamate; MSN, medium spiny neuron; PR, progressive ratio; RM,
repeated measures; SEM, standard error of the mean; VAChT, vesicular acetylcholine transporter; VGLUT3, vesicular glutamate transporter.
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worse, than those in mice with specific loss of VAChT alone. These results demonstrate that the ability to secrete two different neurotransmitters allows CINs to exert
complex modulation of a wide range of behaviors.
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I N T RO DU CT ION

The striatum is the principal input structure of the basal
ganglia and is involved in regulating a variety of behaviors
such as motor function, cognition, motivation, and habit
formation.1,2 The coordination of these roles relies on striatal neurons integrating information received from surrounding brain areas including the cortex, midbrain and
thalamus.2,3 Dysfunction in striatal regulation has been
associated with a variety of diseases such as Parkinson's
disease,4,5 Huntington's disease6,7 and addiction.8,9
Additionally, recent studies have shown that striatal dysregulation may also correlate with obsessive-compulsive
disorder,10,11 eating disorders,12,13 schizophrenia,14,15 and
bipolar disorder.16,17 Therefore, an understanding of how
the striatum is regulated is essential to understanding disease and developing treatments.
There is an emerging acceptance that a critical component of the striatal circuitry in both health and disease is
cholinergic interneurons (CINs). CINs compose only 2%–
3% of all striatal neurons but they represent one of only two
sources of acetylcholine (ACh) in the striatum (the other
being brainstem cholinergic afferents18). CINs are critical
for the integration of information processing in the striatum
and modulating striatal output.2,19 CIN signalling has been
associated with cognition, movement, reward responses
and the regulation of dopamine release.20–22 ACh release
from CINs can have either antagonistic or agonistic effects
on dopamine release, depending on the specific striatal sub-
region and the activity state of local neurons and microcircuits.23,24 Therefore, to understand the dynamics of striatal
dopamine, we need to understand the role played by CINs.
The roles of ACh released by CINs have been studied
in various behavioral paradigms, by either lesioning CINs
or by using optogenetics and/or chemogenetics to control
their activity. However, what is often overlooked is that
CINs express both the vesicular acetylcholine transporter
(VAChT) and the vesicular glutamate (Glu) transporter
3 (VGLUT3), and thus release both ACh and Glu.1,25–27
Thus, lesion and activation/inhibition strategies do not
disentangle the individual impact of ACh and Glu released by CINs. Importantly, recent studies have indicated
that ACh and Glu released by CINs have distinct functions
and potentials as therapeutic targets.1,13,25–29

In this study, we used three genetically modified mouse
lines which have intact CINs but lack either VAChT or
VGLUT3 or both transporters (VAChT and VGLUT3, double knockouts) in these neurons. This strategy allows us to
examine individual and complementary roles for ACh and
Glu released by CINs in reward-evoked dopamine release,
response to dopaminergic drugs, and dopamine-dependent
behaviors. To investigate complex motor learning and response selection that shows sensitivity to D2 drugs, we
adapted for use with mouse touchscreens a heterogeneous
sequence test developed by Robbins and collaborators.30

2
2.1

|

MATERIALS AND METHO D S

|

Animals

The use and care of the animals was conducted in agreement with the Canadian Council of Animal Care guidelines and the animal protocols approved by the University
of Western Ontario (protocols #2016-103, 2016-104). The
generation of VAChTflox/flox and VGLUT3flox/flox mutant
mouse lines was described previously.31,32 LoxP sequences
flanking the VAChT gene do not interfere with cholinergic
marker expression; both VAChTflox/flox and VGLUT3flox/flox
mice do not differ from wild-type littermates behaviorally.31,33 The generation of dopamine receptor 2 (D2)-Cre
mice [Tg(Drd2-cre)44Gsat; GENSAT] has been described.34
D2-Cre mice were backcrossed for at least four generations
to C57BL6/J upon arrival to our laboratory. To generate
the VAChTD2-Cre-flox/flox (VAChTcKO) mouse line, we first
crossed VAChTflox/flox (generated as hybrid C57BL/6;129/
SvEv and posteriorly backcrossed 10× to C57BL6/J) with
D2-Cre mice (obtained from MMRRC as mixed B6/129/
Swiss/FVB background, backcrossed 5× to C57BL6/J
in our laboratory). Littermates VAChTD2-Cre-flox/wt and
VAChTflox/wt generated were intercrossed to generate
VAChTD2-Cre-flox/flox and VAChTflox/flox. To generate the
VGLUT3D2-Cre-flox/flox (VGLUT3cKO) mouse line, we
crossed VGLUT3flox/flox (C57BL6/N background) to D2-Cre
mice. Littermates VGLUT3D2-Cre-flox/wt and VGLUT3flox/wt
were intercrossed to generate VGLUT3D2-Cre-flox/flox and
VGLUT3flox/flox. Biochemical and molecular characterization of VAChT and VGLUT3 deletions with the D2-Cre
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driver were previously shown (Tables 1 and 2).13 Double
knockout mice (VAChT-VGLUT3D2-Cre-flox/flox, DKO) were
obtained by first intercrossing the VAChTD2-Cre-flox/flox mice
with VGLUT3flox/flox mice. Cohorts of mice used in the
present studies were generated by breeding littermates
VAChTD2-Cre-flox/flox; VGLUT3flox/flox to VAChTflox/flox;
VGLUT3flox/flox.

2.2

|

Study design

Studies were performed on 2- to 10-month-old male mice
(Table 1). For this initial exploratory work, to understand
the behavioral consequences of co-transmission from
CINs, we studied male mice given lack of the resources
needed to maintain and test larger cohorts that would
be necessary to study sex as a biological variable. Three
independent cohorts of mutant mice and littermate controls were used to perform different behavioral tasks
(Figure 1). Each cohort performed the behavioral tasks
once (no technical replicates). Cohort 1 was used to analyze dopamine dynamics, cohort 2 performed touchscreen
tasks and cohort 3 performed locomotion.
The N values for each group of animals can be found in
Figure 1 and in Tables S1–S3. Power analysis was not formally
calculated prior to the experiments. Typical sample sizes in
experiments using Bussey-Saksida Touchscreen is between 7
TABLE 1

|
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and 13 mice per group.35–38 Based on these previous studies
we assigned a minimum of 10 animals per genotype.
Animals were housed in groups of two to four per cage
in a temperature-controlled room with a 12:12 light–dark
cycle. Food and water were provided ad libitum until behavioral testing upon which mice were subjected to mild food
restriction (85%–90% of their original weight or 24.5–25.0 g,
whichever was lower). While on food restriction, mice were
weighed daily, and their weights were kept in a required
range. Food-restricted mice were separated and housed
individually (due to fighting) or in groups of two per cage.
Mice were randomized for behavioral tests and the experimenter was blind to the genotype [following the ARRIVE
guidelines39]. Experiments were performed between 9 a.m.
and 6 p.m. and mice were tested during the light cycle.

2.3

|

Quantitative PCR

For mRNA analysis, tissue samples were frozen on dry ice
and kept at −80°C until use. RNA was extracted and purified using the Aurum Total RNA Kit (catalog #7326830,
Bio-Rad, Mississauga, ON, Canada), according to the
manufacturer's instructions. First-strand cDNA was synthesized using the High-Capacity cDNA Transcription
Kit (catalog #4368814, Thermofisher Scientific, Waltham,
MA, USA) according to the manufacturer's instructions.

Mouse lines used in this study

Mouse line

Description

Genotype

Littermate control

Reference

VAChTcKO

VAChT deletion in D2
expressing neurons

D2Cre+/−; VAChTflox/flox

VAChTflox/flox

Guzman et al. 20111;
Favier et al. 202013

VGLUT3cKO

VGLUT3 deletion in D2
expressing neurons

D2Cre+/−; VGLUT3flox/flox

VGLUT3flox/flox

Favier et al. 202013

DKO

VAChT and VGLUT3
deletion in D2
expressing neurons

D2Cre+/−;
VAChTflox/flox-VGLUT3flox/flox

VAChTflox/flox-VGLUT3flox/flox

This paper

T A B L E 2 Expression levels of
vesicular transporters in mutant mouse
lines as measured with immunoblotting

Protein expression level (% of littermate
controls)a

VAChTcKO (%)

VGLUT3cKO (%)

VAChT

20

100

VGLUT3

100

10

VAChT

100

100

VGLUT3

100

100

VAChT

50

100

VGLUT3

100

100

Striatum

Hippocampus

Cortex

a

This is summarized data from matched littermates used in previous D2-Cre studies.1,13
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FIGURE 1

Experimental time course

After reverse transcription, the cDNA was subjected to
quantitative PCR on a CFX Opus Real-Time PCR System
(Bio-Rad) by using SensiFast SYBR Green PCR Master
Mix (catalog #BIO-98050, FroggaBio Inc., Concord, ON,
Canada) according to the manufacturer's instructions.
Relative quantification of gene expression was done with
the 2−ΔΔCt method, using β-actin gene expression to normalize the data. The following primers were used to assess
mRNA levels. VAChT-F: CCCTTTTGATGGCTGTGA and
VAChT-R: GGGCTAGGGTACTCATTAGA, VGLUT3-F:
ATTCGGTGCAACCTTGGAGT
and
VGLUT3-R:
TGAAATGAAGCCACCGGGAA, ChAT-F: TTCTGCT
GTTATGGCCCTGTGGTA: and ChAT-R: TCAAGATT
GCTTGGCTTGGTTGGG. To analyze differences between
control (n = 4) and KO (n = 7) mice, two-tailed unpaired
t-tests were used.

2.4 | Fiber photometry and dopamine
reward response
To assess in vivo dynamics of dopamine in response
to reward within the nucleus accumbens shell, real-
time fluorescence intensity (V) was recorded using
the recently developed D2-based genetically encoded
GRABDA2m dopamine biosensor.40 Mutant mice (8–
20 weeks) and their control littermates were anesthetized using isoflurane administered at a 4%–5%
induction rate. Mice were then placed in a stereotaxic
frame while anesthesia was maintained at 1.5%–3%. A
heating pad was placed under the mice to maintain body
temperature (37°C). The top of the skull was exposed

and holes were drilled to implant two skull screws and
an unilateral microinjection (500 nl, 100 nl/min) of
AAV-hSyn.GRABDA2m (3.1 × 1013 gc/ml) at the following coordinates from Bregma (AP: 1.6 mm, ML: 0.3 mm,
DV: 3.9 mm).41 Injectors were left in place for 5 min and
then removed slowly. Low-auto-fluorescence optic fiber
implants (400 μm O.D, 0.48 NA, Doric Lenses, Quebec
City, QC, Canada) were unilaterally inserted just above
the injection site.
Prior to experimentation, mice underwent a 4-week
recovery period to allow for GRABDA2m expression
within the nucleus accumbens shell. Mice were then
food restricted to 85%–90% of their post-recovery body
weight to motivate them to perform a simple reward
response task using automated touchscreen systems
(Lafayette Instruments, Lafeyette, IN, USA). Each trial
consisted of the delivery of 2 µl strawberry milkshake
(Neilson Dairy, Toronto, ON, Canada) coupled with a
1 s-long tone and a light illuminating the reward magazine receptacle. Mice underwent a total of 20 consecutive trials with pseudo-random inter-trial intervals
ranging between 30 and 90 s.
The photometry system was equipped with a fluorescent mini-cube (Doric Lenses) to transmit sinusoidal 465-
nm LED light modulated at 572 Hz and a 405-nm LED
light modulated at 209 Hz. LED power was set at ~30 μW.
Fluorescence from neurons was collected from the optic
fiber tip and transmitted back to the mini-cube, amplified
and focused into an integrated high sensitivity photoreceiver (Doric Lenses). The signal was demodulated for the
brightness produced by the 465-nm excitation (dopamine-
dependent GRABDA fluorescence) versus isosbestic

KLJAKIC et al.

405-nm excitation (dopamine-independent GRABDA),
which allowed for correction from bleaching and movement artifacts. Fluorescent modulated real-time signal
from each LED was sampled at 12 kHz and then demodulated and decimated to 100 Hz using Doric Studio (Doric
Lenses). For analysis, the least-squares fit was applied to
the isosbestic 405-nm signal and used to normalize the
465-nm signal as follows: ΔF/F0 = (465-nm signal—fitted
405-nm signal)/(fitted 405-nm signal). A Time-to-live
(TTL, timestamp) output signal (100 ms) from ABET II
(Lafayette Instruments) was delivered when mice broke an
infrared beam located inside the reward magazine receptacle and it was used to time-lock reward collection with
ΔF/F0 dopamine dynamics from the nucleus accumbens.
The analysis code used to process the raw fluorescence
data is free for download at this link: https://mousebytes.
ca/comp-edit?repolinkguid=e46739ed-1154-4d85-bf8c-
5cba6b677a74 (Fiber Photometry Analysis Code).

2.5

|

Analyses of fiber photometry data

Fluorescent modulated real-time signal from each LED
was collected for 20 consecutive reward-delivery trials.
The height peak and area under the curve was calculated
for each trial. Dopamine responses were then averaged to
achieve the final result. To analyze differences between
control and KO mice, two-tailed unpaired t-tests were used.

2.6

|

Immunofluorescence

Once behavioral testing was completed, mice were deeply
anesthetized with 100 mg/kg ketamine with 25 mg/kg
xylazine, after which they were perfused with ice-cold
phosphate-buffered saline followed by 4% paraformaldehyde. The brain from each mouse was then extracted,
post-fixed in 4% paraformaldehyde overnight at 4°C, and
then transferred to 20% sucrose in phosphate-buffered
saline and stored at 4°C prior to sectioning. Coronal sections (30 μm) of the nucleus accumbens were cut using
a cryostat (Leica 1950S, Leica Biosystems, Buffalo Grove,
IL, USA), and stored in cryoprotectant (2 parts phosphate-
buffered saline, 1 part ethylene glycol, 1 part glycerol) at
−20°C. For immunofluorescent labelling, the sections
were washed three times in phosphate-buffered saline
and then blocked for 2 h at room temperature in a solution of phosphate-buffered saline, 0.1% Triton X-100
(PBS-T), 0.1% bovine-serum albumin and 4% normal goat
serum (catalog #S-1000, Vector Laboratories, Burlingame,
CA, USA). After blocking, the sections were then incubated for 48 h at 4°C with rabbit anti-GFP polyclonal primary antibody conjugated with Alexa Fluor 488 (1:1000,
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catalog #A-21311, Thermofisher Scientific) diluted in PBS-
T, 0.1% bovine-serum albumin and 2% normal goat serum.
Sections were then washed three times in phosphate-
buffered saline, mounted on to SuperFrost+ slides and
cover slipped with Vectashield Vibrance antifade medium with DAPI (catalog #H-1800, Vector Laboratories).
Imaging was conducted with an EVOS FL Auto 2 Imaging
System (Thermofisher Scientific) to visualize the probe
placement and viral-GFP expression on each section.

2.7 | Touchscreen behavioral
assessments
All touchscreen-based tasks (fixed ratio-FR and progressive ratio-PR, extinction protocol and the heterogenous sequence task) were conducted using automated
Bussey–Saksida Mouse Touchscreen Systems model
81426 (Campden Instruments, Loughborough, England).
Schedules were designed and the data were collected
using the ABET II Touch software v.2.15 (Lafayette
Instruments). As mice were motivated by a food reward (strawberry milkshake, Neilson Dairy), they had
to undergo a mild food restriction as described above.
For all touchscreen tasks, mice were trained 5 days a
week (1 session per day) and each trial required a correct response to be made. In all tasks, the time to press
correct window (correct response latency) and time to
collect reward (reward collection latency) were measured in addition to other task-specific variables. The
order of the touchscreen tasks was as follows: 4 sessions of habituation → pre-training until pre-defined
criteria were reached → FR1, FR2, FR3, FR5 until criteria were reached → 3 sessions of PR4 followed by
3 sessions of FR5 for re-baselining and again 3 sessions
of PR4 followed by 3 more sessions of FR5 → 1 session
of PR8 → Extinction training phase until criteria were
reached (minimum 5 sessions) → 6 sessions of Extinction
testing phase → 1 session of FR1 followed by 2 sessions
of FR5 to ensure renewed performance after extinction → 13 sessions of heterogeneous sequence, the two
last sessions with the injection of haloperidol or vehicle
as will be further described (see schematic in Figure 1).

2.8

|

Habituation and pre-training

Mice were habituated to the touchscreen apparatus at the
beginning of the touchscreen-based behavioral testing.
The habituation and pre-training procedure are described
in detail elsewhere.42–44 In short, during the habituation,
mice were exposed to the touchscreen apparatus for 10–
40 min per day and they were gradually habituated to

6 of 21
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the milkshake reward with a tone playing whenever the
mouse entered the reward magazine.
The habituation was followed by pre-training where
the reward was associated with the presentation of a stimulus on the touchscreen. The stimulus appeared randomly
in one of the five windows/locations and after 30 s, it was
removed, and a reward was given paired with a tone. If
the mouse touched the screen while the image was displayed, it immediately received a reward. Once the mouse
collected the reward a new trial was initiated. The pre-
training session was repeated until the mouse reached the
criterion of completion of 30 trials within 60 min for one
day. After reaching this criterion (usually within a single
session), mice were moved to the Fixed Ratio tasks.

2.9 | Homogeneous tasks: Fixed and
progressive ratio tasks
The fixed and progressive ratio tasks (FR and PR, respectively), which assess operant responding were performed
as described by Heath et al. (2016) with slight modifications.45 Both are homogeneous touchscreen tasks that
rely on mice emitting multiple touches on the same grid
to receive a reward (in contrast to heterogenous tasks
that require touches across different grids). In both the
FR and PR tasks, trials were not required to be initiated
by magazine entrance and started automatically after a
5 s inter-trial interval. Each response in both the fixed
and progressive ratio tasks was accompanied by a short
click-like tone. If the required number of responses was
reached, the reward tone was played, the reward was delivered into the illuminated magazine and the stimulus
was removed from the screen for 500 ms.
In the FR tasks, mice were required to make a fixed
number of responses (nose-pokes) to a white square
stimulus located in the center of the screen in order to
get a reward. The number of required responses ranged
from 1 to 5 and always stayed the same in a given session. Testing was initiated with a session where only one
response was required (FR1) and after reaching criterion
(completing 30 trials in 60 min for two consecutive days)
the mice were transferred to a session with a more demanding number of responses (FR2, FR3 and FR5). The
criterion in the more demanding protocols was the same
as in FR1 (completing 30 trials in 60 min) except only one
day of reaching this criterion was required. The mice were
moved through the task based on their own level of performance (not influenced by performance speed of littermates) to ensure they did not get overtrained in the task.
Performance was analyzed for the first session of each
fixed ratio stage (e.g., if the mouse required 3 sessions to
reach FR5 criteria, session 1 was used for analysis). After

reaching criterion in the last FR session, the mice were
transferred to the progressive ratio (PR) task.
In the PR task, the number of responses required to obtain the reward was actively increasing during a single session. In every new trial, the number of responses required
was increased by 4 during a single session (PR4, so the number of responses was 4, 8, 12, 16 etc. in the session). The PR
session was terminated automatically after 60 min or after
5 min of inactivity (no response was made and no magazine entry). Mice underwent three consecutive sessions of
the PR task followed by three sessions of FR5 (re-baseline)
and by another 3 sessions of the PR task and then three sessions of FR5. After that, one session of the more demanding
PR8 task was introduced, where the required number of responses progressively increased by 8 within a single session.
The maximum trials mice were willing to perform (breakpoint) was analyzed for all PR4 and PR8 sessions.

2.10
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Extinction procedure

Following the completing of the homogenous tasks (FR/
PR), the extinction task was used to dissociate center
window pressing from reward. A protocol described by
Nithianantharajah et al. (2013) was followed with minor
modifications.46 During the extinction training phase,
mice were required to respond to a white square stimulus
presented in the center of the screen in order to obtain a
reward. The stimulus remained on the screen until a response was made and was removed afterwards together
with the appearance of a tone, magazine illumination and
reward delivery. The training criterion was defined as
completing 30 trials within 12.5 min for five consecutive
sessions. After reaching this criterion, mice were transferred to an extinction probe phase in which responses to
the stimulus were no longer rewarded nor accompanied by
any other feedback. During the probe sessions, the stimulus was displayed for 10 s and then it was automatically removed if a response was not made. After a 10 s inter-trial
interval, a new trial (stimulus presentation) was automatically initiated. The session was terminated after 30 trials
(maximum time of 1 session when no response was made
was 12.5 min). The extinction probe phase was conducted
over the course of six days (one session per day).

2.11

|

Heterogenous sequence task

To better understand operant responding in mutant mice,
we modified the protocol of the heterogeneous sequence
task as described by Keeler et al. (2014)30 and adapted it
for touchscreens (see Janickova, Kljakic et al. 2021).47
Similar to the FR and PR tasks, mice had to respond a

KLJAKIC et al.

white square stimulus multiple times in order to get a reward. However, in the heterogeneous sequence task, the
stimulus was presented sequentially in five different locations on the screen from the left to the right, so mice
were required to make five sequential responses, each to
one of the five windows. As the stimulus appeared in a
row from the left to the right side of the screen, the distance between two successive stimuli was always identical. A correct response to each location was accompanied
by a short click-like tone and the stimulus disappeared
for 500 ms. After the final response was made to the fifth
location, the mouse was required to enter the magazine
after which the reward tone was played, and the reward
was delivered. Every new trial was automatically initiated
5 s after reward collection (5 s inter-trial interval) and a
maximum of 30 trials could be completed within 60 min
in each session. This was performed for 11 consecutive
days after which the mice underwent treatment before
performing the heterogeneous sequence sessions. On days
12 and 13, mutant mice and littermate controls were intraperitoneally injected with vehicle (0.2% lactic acid) or D2
antagonist haloperidol (0.1 mg/kg), respectively, 30 min
prior to testing in the touchscreens. Haloperidol (catalog
#H1512, MilliporeSigma, Oakville, ON, Canada) was dissolved in 0.2% lactic acid.

2.12

|

Locomotor activity

Locomotor activity was measured in an open field arena
(20 cm × 20 cm platform with 30 cm high walls) as previously described31 and movement in the arena was recorded by AccuScan Instruments Inc. (Columbus, OH).
Mice were placed in the centre of the apparatus and allowed to freely explore the novel environment for 120 min
during the light phase (between 9 a.m. and 5 p.m.). For
intersession habituation, mice spent 120 min in the same
open field apparatus for three consecutive days. Total distance travelled (converted from beam breaks to cm) was
calculated at 5-min intervals. VAChTflox/flox control locomotor data has been previous published in Favier et al.,
2020—fig. S7N.13 It was used here only to compare general exploration for the three control mouse lines used in
the experiment. To analyze differences between control
and KO mice, two-way repeated measures ANOVA with
Sidak's multiple comparisons post-hoc test was used.

2.13

|

FR analyses

In all FR stages (FR1, FR2, FR3, and FR5) the time it took
to complete 30 trials in the first session was analyzed to
evaluate differences in learning of the operant task. Several
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parameters were analyzed during the same session:
Number of Blank Touches—touches on non-illuminated
windows; Correct Response Latency—reaction time for
correct response; Reward Collection Latency—reaction
time to collect the reward on correct trials. To analyze differences between control and KO mice, two-way ANOVA
with Sidak's multiple comparisons post-hoc test or two-
tailed unpaired t-tests were used (a repeated measures
ANOVA was only used for FR1 time to complete task).

2.14

|

PR analyses

In the PR stages, the breaking point (maximum trials
mice were willing to perform) was used to analyze motivation. Several parameters were analyzed during the
same session: Number of Blank Touches—touches on
non-illuminated windows; Correct Response Latency—
reaction time for correct response; Reward Collection
Latency—reaction time to collect the reward on correct
trials. To analyze differences between control and KO
mice, two-way repeated measures ANOVA with Sidak's
multiple comparisons post-hoc test or two-tailed unpaired
t-tests were used.

2.15

|

Heterogenous sequence analyses

In all heterogenous sequence sessions, the time it took
to complete 30 trials was analyzed to evaluate differences in learning of the operant task. Other parameters
were analyzed across the same sessions: Number of
Blank Touches—touches on non-illuminated windows;
Reward Collection Latency—reaction time to collect the
reward on correct trials. Slowing factor was also analyzed on the last sequence session (Day 11). Initiation
Factor was calculated as a ratio of correct response latency Grid 1 ÷ control average correct response latency
Grid 1. Termination Factor was calculated as a ratio of
reward collection latency ÷ control average reward collection latency. To analyze differences between control
and KO mice, two-way repeated measures ANOVA with
Sidak's multiple comparisons post-hoc test was used
(a non-repeated measures ANOVA was only used for
blank touches across grids).
For drug test days, performance in one session of the
heterogeneous sequence task was assessed. Performance
speed was calculated as correct trials completed over a
specific time window. The rest of the task parameters were
calculated as a ratio of haloperidol performance ÷ vehicle performance: Time to Complete Task, Number of
Blank Touches—touches on non-illuminated windows
(total and per grid); Correct Response Latency—reaction

8 of 21

|

KLJAKIC et al.

  

time for correct response per grid. Slowing factor was also
analyzed for the drug sessions. Initiation Factor was calculated as a ratio of correct response latency Grid 1 haloperidol session ÷ correct response latency Grid 1 vehicle
session. Termination Factor was calculated as a ratio of
reward collection latency haloperidol session ÷ reward
collection latency vehicle session. To analyze differences
between control and KO mice, two-way repeated measures
ANOVA with Sidak's multiple comparisons post-hoc test or
two-tailed unpaired t-tests were used (a non-repeated measures ANOVA was only used for blank touches and correct
response latency across grids). One VAChTcKO control
mouse (VAChTflox/flox) did not receive the proper dose of
haloperidol so was excluded from analysis of drug test days.

2.16

|

Statistical analysis

All collected data were statistically analyzed and
graphed using GraphPad Prism 8.0. Data were plotted as mean ± SEM. Normality was evaluated with the
D'Agostino & Pearson test when comparing two datasets
(a Shapiro-Wilks normality test was only used for the
photometry data as the n-value was low). A Student's t-
test was used for comparisons between two experimental
groups and a two-way analysis of variance (ANOVA) was
conducted to compare several treatment groups. For tasks
that included more than one session, ANOVA with repeated measures (RM) was used. If data did not pass normality, a Mann-Whitney test was performed. A Sidak's post
hoc test was used wherever appropriate. p Values < .05
were considered as statistically significant. Touchscreen
data on latencies were evaluated for irregularities. In particular, large high value correct response latencies and 0 s
reward collection latencies are often a result of software
errors. Any latency value beyond Average ± 3 (Standard
Deviations) was automatically removed from the dataset.
These data were then analyzed with a mixed-effects test.
The same outlier formula was used to evaluate the rest of
the touchscreen parameters. Full statistical tables are provided for all data (Tables S1–S3), with main parameters
also described in the text.
TABLE 3

|

RESULTS

3.1 | Mice with a striatal knockout of
VAChT or VGLUT3
To be able to assess the impact of co-transmission from
CINs of the striatum we used the Cre-LoxP approach to
selectively delete the vesicular transporters for ACh and
Glu. To target striatal CINs but leave other populations
of cholinergic neurons intact, we chose the promoter
for the D2 receptor as the Cre driver (Table 1). Choline
acetyl-transferase (ChAT)-Cre was not used as the Cre
driver since crossing ChAT-Cre mice with VAChTflox/flox
mice would silence VAChT in all cholinergic neurons
of the body, including motor neurons causing respiratory paralysis. Notably, global homozygous VAChT-KO
mice have a major muscular deficit and die shortly after
birth48 and even selectively targeting VAChT in motor
neurons causes weakness and death after few months.49
D2-Cre avoids this problem but still retains some precision with transporter deletion as it is highly expressed
on striatal CINs and also allows for the use of the same
Cre driver for the double knockout mice. Specifically, we
previously established, using in situ hybridization and immunoradiography, that using D2-Cre as a driver targets
transporter expression in the striatum but not in the pedunculopontine or motor nuclei of the brainstem.1,13 We
also demonstrated that D2-Cre expression by itself does
not induce striatal-dependent behavioral phenotypes.1,13
Furthermore, we previously evaluated how D2-Cre affects
the loss of VAChT and VGLUT3 expression in different
brain regions of VAChTcKO and VGLUT3cKO mice using
immunoblotting (see summary in Table 2).1,13 In particular, VAChT and VGLUT3 expression is almost completely
abolished in the striata of the respective lines. Assessment
of striatal-specific vesicular transporter expression levels showed the greatest degree of decrease in the dorsal
striatum (see summary in Table 3).13 Examination of
DKO mice, revealed a significant decrease in striatal expression of VAChT mRNA (Figure S1A; unpaired t-test:
t(9) = 5.685, p = .0003) and VGLUT3 mRNA (Figure S1B;
unpaired t-test: t(9) = 3.749, p = .0046), yet no changes in

Striatal-specific expression levels of vesicular transporters in mutant mouse lines as measured with immunoautoradiography

Striatal subregion

a

3

VAChTcKOa

VGLUT3cKOa

VAChT expression (% of littermate controls)

VGLUT3 expression (% of littermate
controls)

Nucleus accumbens

~50

~70

Dorsomedial striatum

~20

~20

Dorsolateral striatum

~20

This is summarized data from matched littermates used in previous D2-Cre studies.

~15
13
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ChAT mRNA levels (Figure S1C). Notably, using D2-Cre
to solely delete VAChT does not cause changes in mRNA
and protein expression of VGLUT3 and vice versa.13
Consequently, we focused on behaviors that are known
to be striatal specific (behavioral tasks are depicted in
Figure 1).
Previous experiments have characterized ACh1,13 and
dopamine release using microdialysis and amperometry13,50 in VAChT and VGLUT3 deficient mice. VAChT and
VGLUT3 deletions differentially affect KCl-induced dopamine release in the striatum of anesthetized animals.13,50
To determine if in freely behaving mice dopamine signalling is also differentially affected by the elimination of
VAChT or VGLUT3, we transduced the genetic-encoded
dopamine sensor, GRABDA2m into the nucleus accumbens
shell of mutant mice and their littermate controls using
a viral vector (see schematic Figures 2A and S2). The
GRABDA2m is a GPCR-D2 based biosensor that allows for
real-time detection of dopamine dynamics.40 As dopamine neurons strongly fire in response to reward, we used
reward delivery (provided in a touchscreen reward magazine receptacle when a 1 s-long tone was played) to elicit
dopamine signalling in the nucleus accumbens. Notably,
it has been demonstrated that reward collection leads to
a phasic increase of extracellular dopamine levels in the
nucleus accumbens.51,52 We found that when reward was
elicited, mice immediately moved towards the magazine
receptacle, and as the task progressed, they spent more
time sitting in front of the port, waiting for reward to be
delivered at a pseudo-random intertrial duration (30–90 s).
Control mice and VAChTcKO mice demonstrated an increase in reward-evoked dopamine response that lasted 5 s
(Figure 2). However, VAChTcKO mice presented a smaller
peak (Figure 2C; unpaired t-test: t(13) = 2.980, p = .0106)
and the overall level of response was lower (area under the
curve, Figure 2D; unpaired t-test: t(13) = 5.401, p = .0001)
compared to controls. In VGLUT3cKO mice the dopamine peak height was not significantly different between
VGLUT3cKO mice and controls (Figure 2E,F). However,
the duration of the peak as well as the total amount of dopamine signal (estimated by the area under the curve) was
significantly higher in VGLUT3cKO mice compared to littermate controls (Figure 2G; unpaired t-test: t(12) = 2.868,
p = .0141).
To determine the consequences that arise when CINs
are completely silenced in their ability to release either
ACh or Glu, we used VAChT and VGLUT3 double KO
mice (DKO, Table 1).
Interestingly, the reward-evoked dopamine response
in DKO mice presented a combination of characteristics observed in both VAChTcKO and VGLUT3cKO mice
(Figure 2H). That is, similar to VAChTcKO mice, DKO
mutants had a lower height of signal peak (Figure 2I;
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unpaired t-test: t(9) = 2.714, p = .0238). However, they
do not differ in area under the curve compared to littermate controls (Figure 2J); this is because, similar to
VGLUT3cKO mice, they show a lingering dopamine response. We also evaluated VAChTflox/flox-VGLUT3flox/flox
(control) mice and found that similar to the other control lines (VAChTflox/flox, VGLUT3flox/flox) they had an increase in reward-evoked dopamine response that lasted
5 s (Figure 2). These three control lines did not differ in
height peak (data not shown, One-way ANOVA; main effect of genotype: F(2,18) = 0.03329, p = .9673) nor area
under the curve (data not shown, One-way ANOVA; main
effect of genotype: F(2,18) = 0.9781, p = .3951). To note,
for all investigated genotypes we found no significant differences in the reward responses across time (data not
shown, 50–70 reward collection trials/mouse). Taken together, these results suggest that CIN-expressed VAChT
and VGLUT3 differentially modulate reward-evoked dopamine signalling in freely moving mice.

3.2 | DKO mice show a learning
impairment in the initial phase of the fixed
ratio touchscreen task
To determine how the absence of VAChT or VGLUT3
from CINs affects striatal-modulated behaviors, we tested
VAChTcKO, VGLUT3cKO and DKO mice in a battery
of reward-based operant touchscreen tasks (see schematic in Figure 1). In these tasks, mice had to perform
multiple touches to either the same or different touchscreen grids, referred to as either homogeneous (FR, PR
task) or heterogeneous sequence tasks, respectively, see
also Keeler et al. (2014).30 We first evaluated mice in the
fixed ratio (FR) task, where mice had to press a central
illuminated window a fixed number of times to receive
a reward (Figure 3A). We found that the performance of
VAChTcKO mice did not significantly differ from littermate controls in terms of time to complete trials, touches
on non-illuminated windows (blank touches), time to
press correct window (correct response latency) and time
to collect reward (reward collection latency, Figures 3 and
S3). This suggests VAChTcKO mice do not struggle completing this simple operant task.
VGLUT3cKO mice also did not significantly differ
from controls in the FR1 session (FR1, Figures 3 and S3).
However, these mutant mice performed the more demanding FR sessions faster (Figure 3H; Two-way ANOVA;
main effect of genotype: F(1,69) = 10.45, p = .0019), measured as a decrease in blank touches (Figure 3I; Two-
way ANOVA; main effect of genotype: F(1,69) = 5.154,
p = .0263) and a shorter correct response latency
(Figure S3G; Two-way ANOVA; main effect of genotype:
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F I G U R E 2 ACh and Glu released by CINs have opposing effects on dopamine response to reward. (A) Schematic of dopamine
recording. (B–J) Dopamine parameters recorded in response to reward: (B, E, H) overall signal change, (C, F, I) height of the signal peak and
(D, G, J) area under the curve. Data are expressed as mean ± SEM, *p < .05, ***p < .001. Summary statistics in Table S1

F(1,68) = 7.556, p = .0077). Although, no change was detected in reward collection latency (Figure S3H). Together,
these results suggest that the faster completion of the task
by VGLUT3cKO mice compared to their littermate controls is not caused by their higher motivation to obtain

a reward but rather by increased responsiveness to the
reward-related cue (i.e., illuminated position in the touchscreen, with decreased blank touches).
DKO mice, which had both VAChT and VGLUT3 deleted from CINs, were also assessed in the same FR tasks.

KLJAKIC et al.
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F I G U R E 3 DKO mice have a learning impairment in the initial fixed ratio task sessions. (A) Schematic of the fixed ratio touchscreen
task: mice are required to make a fixed number of responses (nose-pokes) to a white square stimulus located in the center of the screen to
receive a reward. (B–M) Parameters recorded during the fixed ratio touchscreen tasks: (B, F, J) time to complete 30 trials for FR1, (C, G, K)
number of blank touches for FR1, (D, H, L) time to complete 30 trials for FR2, FR3 and FR5 and (E, I, M) number of blank touches for FR2,
FR3 and FR5. Data are expressed as mean ± SEM, #p < .05, ##p < .01, ###p < .001. Summary statistics in Table S2

We found that DKO mice were initially slower than wild-
types controls to learn the FR task (FR1) (Figure 3J; Mixed
effect model; main effect of genotype: F(1,23) = 8.195,
p = .0088) but improved to wild-type levels as training
continued (FR3, FR5) (Figure 3L; Two-way ANOVA;
main effect of genotype: F(1,69) = 3.565, p = .0632).
The impaired performance in FR1 was accompanied
by an increased number of blank touches (Figure 3K;
Mann–Whitney test: U = 18, p = .0007), longer correct response latency (Figure S3I; Mann–Whitney test: U = 15,
p = .0011) and reward collection latency (Figure S3J; unpaired t-test: t(23) = 3.328, p = .0029). During FR2-5 training days, there were changes in correct response latency
(Figure S3K; Two-way ANOVA; main effect of genotype:
F(1,68) = 4.519, p = .0372) and reward collection latency
(Figure S3L; Two-way ANOVA; main effect of genotype:
F(1,68) = 4.999, p = .0287) but not in the number of blank

touches (Figure 3M). These results suggest that DKO mice
struggle to initially learn an action-outcome association,
but as training is prolonged they managed to reach the levels of their control mice.
Surprisingly control lines showed differences in operant
performance suggesting that a slight difference of genetic
background in the three lines seems to affect performance
in this task. Since their reward collection latencies were similar across all fixed ratio tasks (data not shown, FR1-5: Two-
way ANOVA; main effect of genotype: F(2,149) = 0.2757,
p = .7594), the impact of the genetic differences seems
specific to the task parameters. This observation argued for
the evaluation of the performance of mutant mice based
on comparisons with their littermate controls. To note, the
period at which the task was run could also lead to some
variability, as groups of mice were evaluated in different
timeframes, due to our limited capacity to test all groups
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simultaneously (however, mutant mice were always tested
concurrently with their respective littermate controls).

3.3 | DKO mice show an increased
rate of responding during the progressive
ratio task
We next evaluated motivation using the progressive ratio
(PR) touchscreen task where to receive a reward, mice had
to press a central illuminated window a number of times
that was incrementally increased each trial (Figure 4A).
Both VAChTcKO and VGLUT3cKO mice did not differ
from their respective littermate controls in both PR4 and

KLJAKIC et al.

PR8 (Figures 4 and S4). VAChTcKO and VGLUT3cKO
mice did not differ in maximum trials they were willing
to perform (breakpoint), blank touches, correct response
latency and reward collection latency in both PR4 and
PR8. This supported the notion that the motivation is not
altered in these two mutant mouse lines.
Notably, we found that DKO mice had a higher breakpoint in PR4 (Figure 4J; Two-way RM ANOVA; interaction
effect of time × genotype: F(5,115) = 2.963, p = .0149) and
in the more demanding PR8 (Figure 4L; unpaired t-test:
t(21) = 3.399, p = .0027) compared to littermate controls.
Interestingly, the increased motivation was not observed
at the beginning of the task and only appeared after
two days of training in PR4. On the third day, while the

F I G U R E 4 DKO mice have higher responding during the progressive ratio tasks. (A) Schematic of the progressive ratio touchscreen
task: mice are required to make responses (nose-pokes) that are actively increasing in a single session, on a white square stimulus located
in the center of the screen to receive a reward. (B–M) Parameters recorded during the progressive ratio touchscreen tasks: (B, F, J) breaking
point (maximum trials mice were willing to perform) in PR4, (C, G, K) number of blank touches in PR4, (D, H, L) breaking point in PR8 and
(E, I, M) number of blank touches in PR8. Data are expressed as mean ± SEM, *comparing to matched littermate control parameter, #overall
genotype effect, *p < .05, **p < .01. Summary statistics in Table S2

KLJAKIC et al.

performance of control mice decreased, the mutants' performance developed in the opposite direction (Figure 4J).
This might suggest that the DKO mice are more prone to
developing habitual behavior (nose-poking) rather than
showing higher motivation. The higher breakpoint in PR
tasks was accompanied by an increased number of blank
touches (Figure 4K; Two-way RM ANOVA; main effect of
genotype: F(1,23) = 5.804, p = .0244; Figure 4M; Mann–
Whitney test: U = 21, p = .0014), but no change in reward
collection latency (Figure S4J,L). The correct response latency was also decreased in DKO mice during two particular sessions of the PR4 training while later it matched the
control values (Figure S4I,K).
Prior to performing more touchscreen tasks, we extinguished center pressing behavior using an extinction
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touchscreen task to ensure overtraining would not bias
future results. We found that all experimental mice extinguished center pressing and did so to a similar degree
(Figure S5A; Two-way RM ANOVA; main effect of task
session: F(1,140) = 7050, p < .0001).

3.4 | Sequential learning is influenced by
striatal VAChT
We next assessed response chain learning and complex
motor learning using the heterogenous sequence task.30
Mice were trained to press five grids sequentially in the
touchscreen, from left to right, to receive a reward for
11 sessions (Figure 5A). Early (left) components are

F I G U R E 5 ACh and Glu released by CINs have opposing effects on the speed at which the heterogeneous sequence task is completed.
(A) Schematic of the heterogeneous sequence task: mice are required to make a five sequential responses (nose-pokes) from left to right on a
white square stimulus to receive a reward. (B–M) Parameters recorded during the heterogenous sequence touchscreen task: (B, F, J) time to
complete 30 trials, (C, G, K) number of blank touches, (D, H, L) reward collection latency and (E, I, M) slowing factor during the initial and
final steps of the sequence (speed at which task was started versus ended as a ratio of control latency). Data are expressed as mean ± SEM,
*comparing to matched littermate control parameter, #overall genotype effect, *p < .05, **p < .01, ****p < .0001. Summary statistics in Table S2

14 of 21

|

  

considered distal to reward with late ones (right) proximal to reward. Of note, the correct grids to be pressed
were always sequentially highlighted on the screen, thus
creating light cues that mice could follow. We found that
VAChTcKO mice took longer to complete this task compared to their littermate controls, especially at the beginning of training (Figure 5B; Two-way RM ANOVA;
interaction effect of time × genotype: F(10,240) = 1.880,
p = .0486). This slower performance was accompanied
by a significant change in the number of blank touches
in VAChTcKO mice as they did more nose-pokes on non-
highlighted locations than controls (Figure 5C; Two-way
RM ANOVA; main effect of genotype: F(1,24) = 4.566,
p = .0430). Reward collection latency was not changed
in VAChTcKO mice (Figure 5D). Together these results
indicate that motivation to perform the task was not
altered, yet mutant mice had difficulties following the
sequential cues. Nonetheless, VAChTcKO mice were
able to improve during training. After 11 days of training, VAChTcKO mice responded as quickly as controls
(slowing factor) to both the reward-distal (Initiation:
Grid 1) and reward-proximal (Termination: Reward
Magazine) components (Figure 5E: response latency to
component/average control response latency).
VGLUT3cKO mice showed little alteration in performance compared to their littermate controls. They did
not differ in blank touches (Figure 5G) and reward collection latency (Figure 5H). Nonetheless, VGLUT3cKO
mice did show a non-significant trend to be quicker to
perform the task during early sessions (Figure 5F; comparison first 5 sessions: Two-way RM ANOVA; main effect
of genotype: F(1,23) = 3.999, p = .0575). However, loss
of VGLUT3 in CINs selectively and significantly sped up
performance of early sequence components (Grid 1 correct response latency) but left final components unaltered
after 11 days of training (Figure 5I; Two-way RM ANOVA;
main effect of genotype: F(1,23) = 3.915, p = .06, post hoc
Sidak test: Initiation, p = .0203). This finding suggests that
VGLUT3cKO mice have a better recognition of distal cues.
DKO mice, on the other hand, were slower to complete the heterogeneous sequence task when compared
to their respective controls (Figure 5J: Mixed-effects
model; main effect of genotype: F(1,23) = 7.7889, p = .01)
and made significantly more blank touches compared
to littermate controls (Figure 5K: Mixed-effects model;
main effect of genotype: F(1,23) = 23.61, p < .0001).
This change in performance was not accompanied by
an increased reward collection latency (Figure 5L).
Furthermore, neurochemical silencing of CINs did not
affect performance in early and late sequence components after 11 days of training (Figure 5M). Overall,
these behavioral changes reproduce what we observed
with VAChTcKO mice.
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Similar to the homogenous sequence tasks we saw
differences in the speed of performance of control mice
across genotypes in the heterogeneous sequence task
which we need to consider. Controls from DKO mice
were much faster than the other two control mice and
seem to make more blank touch mistakes. Nonetheless,
reward collection latency was similar between all controls, suggesting that the difference in DKOs is meaningful (data not shown, Two-way RM ANOVA; main effect
of background: F(2,38) = 2.301, p = .1139). Furthermore,
to determine if the changes in performance speed during
the heterogenous task might be related to a more general
hyper or hypoactive phenotype, we examined the performance of mice in locomotor boxes. Using VAChTflox/flox
control data from our previous publication, Favier et al.
(2020), we first compared locomotor activity of the three
controls' lines.13 We find that control mice across the
three lines do not differ in their exploration nor habituation in locomotor boxes (Figure S5B), further suggesting
that the observed behavioral differences of mutant mice
are meaningful.
In multiple previous papers, we have shown that
VAChTcKO mice do not differ in locomotor activity compared to littermate controls (both in exploration and habituation).1,13,29,53 In contrast, we found that VGLUT3cKO
mice are hyperactive but can still habituate to the boxes
(Figure S5C; Two-way RM ANOVA; main effect of genotype: F(1,22) = 11.04, p = .0031), somewhat similarly to global VGLUT3-KO mice.50 Notably, similar to
VGLUT3cKO mice, DKO mice are also hyperactive but
can habituate to their environment (Figure S5D; Two-way
RM ANOVA; main effect of genotype: F(1,21) = 8.388,
p = .0086).

3.5 | Striatal VAChT and VGLUT3 have
dissociative effects on responses to
haloperidol
The performance of rodents in the heterogenous sequence task is highly dependent on dopaminergic function, specifically D2 receptors.30 To further examine
whether DKO mice present features that may be related
to loss of VAChT or VGLUT3, and given the bimodal
regulation of dopamine release operated by CINs,13,50
we tested the sensitivity of touchscreen performance
of both mutant lines to the D2 antagonist haloperidol.
A low dose of haloperidol (0.1 mg/kg) was previously
shown to affect motivated behavior without inducing catalepsy in rodents.54 Notably, Keeler et al. (2014)
demonstrated that the ability to complete a heterogeneous sequence is inhibited by a low dose of D2 antagonist (sulpride).30 Consequently, mutant mice and their
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littermate controls were intraperitoneally treated with
haloperidol (0.1 mg/kg) and assessed in the heterogenous sequence task for one session. In comparison to
vehicle treatment, all three control mouse lines treated
with haloperidol showed a slower speed of performance
(Figure 6A; Two-way RM ANOVA; main effect genotype: F(1,23) = 7.631, p = .0111, Figure 6D; Two-way
RM ANOVA; main effect genotype: F(1,26) = 3.350,
p = .0787; Figure 6G; Two-way RM ANOVA; main effect
of genotype: F(1,26) = 12.78, p = .0014) and took twice as
long to complete the task (haloperidol/vehicle ratio =2;
Figure 6B,E,H). This was accompanied by the absence
of changes in the overall number of blank touches, but
an increased correct response latency across early grids
(haloperidol/vehicle ratio > 1; Figure S6). In controls,
haloperidol selectively and significantly slowed the performance of early sequence components (initiation: ~3-
fold increase) but did not show any effect on the final
components (termination) (Figure 6C,F,I).
In contrast, the performance of VAChTcKO mice
was not significantly affected by haloperidol treatment.

  

|

15 of 21

VAChTcKO mice treated with haloperidol completed the
task as quickly as when they were treated with vehicle
(Figure 6A,B). This was accompanied by no change in
the overall number of blank touches (Figure S6A,B) and
correct response latency (Figure S6C). Notably, while
haloperidol slowed down task initiation in control mice,
VAChTcKO mice were unaffected (Figure 6C).
The performance of VGLUT3cKO mice after haloperidol administration was comparable to control mice
treated with the drug. In comparison to vehicle treatment,
VGLUT3cKO mice treated with haloperidol had slowed
performance (Figure 6D; Two-way RM ANOVA; main effect of genotype: F(1,20) = 9.365, p = .0062, Figure 6E)
that was accompanied by no change in the overall blank
touches but an increased correct response latency across
all grids (Figure S6D–F). Notably, haloperidol slowed
down task initiation in the VGLUT3cKO mice. That is,
when treated with haloperidol VGLUT3cKO mice took
~5× longer to initiate the task than when they were treated
with vehicle (initiation slowing factor = 5.6, Figure 6F).
This effect was specific to the early sequence components

F I G U R E 6 Haloperidol does not impair the touchscreen performance of mice with a loss of VAChT. (A–I) Parameters recorded during
the heterogenous sequence touchscreen task when mice were treated with haloperidol (0.1 mg/kg) and vehicle: (A, D, G) performance
speed over the course of the session, (B, E, H) time to complete 30 trials as a ratio of haloperidol to vehicle performance and (C, F, I) slowing
factor during the initial and final steps of the sequence (speed at which task was started versus ended as a ratio of haloperidol latency versus
saline latency). Data are expressed as mean ± SEM, *comparing to matched littermate control parameter, #overall genotype effect, *p < .05,
**p < .01, ***p < .001. Summary statistics in Table S2
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as terminal components were relatively unimpaired.
Taken together, we find that when treated with haloperidol, VAChTcKO and VGLUT3cKO mice had differing,
often opposite, responses to the drug. While mice lacking
VAChT were unaffected by haloperidol's slowing down
effect, mice lacking VGLUT3 were significantly slowed
down, especially on early sequence components.
Notably, we found that the performance of DKO mice
was almost unaltered by haloperidol. The performance
speed (Figure 6G), overall time to complete the sequence
task (Figure 6H) and number of blank touches (Figure
S6G,H) did not differ when the mice were treated with
haloperidol in comparison to vehicle. However, DKO
mice showed a small increase in correct response latency
across the grids 1–3, which was significantly less than that
of littermate controls and showed a more pronounced
increase in correct response latency on grids 4 and 5
(Figure S6I; Two-way ANOVA; main effect of genotype:
F(1,110) = 9.219, p = .0030). Moreover, the performance
of DKO mice in early and late sequence components was
relatively unaffected (Figure 6I). Overall, the response of
haloperidol administration in DKO mice was similar to
what was observed with VAChTcKO mice and differed
from VGLUT3cKO mice.
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In this study, we compared the functional consequences
of the deletion of VAChT, VGLUT3 or both transporters
in CINs. We show that interference with ACh or Glu have
dissociable effects on dopamine dynamics regulated by a

FIGURE 7

Summary of experimental findings

reward, sensitivity to the D2 antagonist haloperidol, and
complex responses to sequential events (Summarized in
Figure 7). Additionally, we found that deletion of both
VAChT and VGLUT3 from CINs largely recapitulates the
effect of VAChT deletion from CINs, albeit the phenotype
is more severe. This finding suggests that ACh signalling
in striatal microcircuits is the predominant driver of these
reward-based behaviors.
We found that in the nucleus accumbens shell of freely
behaving mice, interference with VAChT expression from
CINs appears to negatively modulate dopamine signalling evoked by a behavioral stimulus, such as reward. In
contrast, interference with VGLUT3 appears to prolong
dopamine signalling. This dissociation of the effects of
ACh and Glu on reward-evoked dopamine signalling is
in agreement with recently published work that examines
dopamine efflux in the nucleus accumbens in response to
chemical stimulation.13,50 Specifically, dopamine efflux
induced by KCl in anesthetized mice with a deletion of
VAChT or VGLUT3 from CINs was decreased or increased,
respectively. These changes in dopamine synaptic transmission may be attributed to ACh and Glu affecting panels
of presynaptic receptors (nAChR, mAChR, mGluRs) and/
or dopamine clearance from the synapse.
In the striatum, it has been proposed that dopaminergic signalling drives sequential learning55,56 with features
of the dopamine signal, including its amplitude and duration, modulating the efficiency of reward-based learning
in an operant task.57–60 Since altering CIN neurotransmitter secretion changed dopamine signalling, we evaluated
if operant behavior was also altered. Notably, we found
that deletion of VAChT and VGLUT3 had contrasting
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effects on performance in sequential response tasks. Loss
of CIN-released ACh led to some difficulties in following a sequence of instrumental cues (illuminated grid
positions) over 11 task sessions. Specifically, VAChTcKO
mice seem to take longer to complete the heterogenous
sequence task, especially during early learning and they
had more difficulties identifying the cues as evidenced by
an increased amount of blank touches. This was not associated with changes in locomotor behavior in a novel environment or impulsivity, as we have previously established
that VAChTcKO mice behave similar to littermate controls
in the locomotor box and 5-choice serial reaction time
tasks.13 In contrast, we found that loss of Glu release from
CINs improved performance in cue-based tasks. Compared
to controls, VGLUT3cKO mice were faster to learn the FR
task and were quicker at completing early sessions of the
heterogenous sequence task. Notably, VGLUT3cKO mice
started the heterogenous sequence task at a quicker rate
after several training days (faster initiation), suggesting
better recognition of cues distal to the reward.30 While
VGLUT3cKO mice were hyperactive in a novel environment, this was not reflected in the latencies to complete
stages of the touchscreen tasks. Whether these behavioral
changes are directly related to altered dopamine signalling
remains unclear and could be tested in the future by direct
manipulations of dopamine secretion. To note, the bulk
dopamine response recorded in our study may not reflect
the millisecond by millisecond measures associated with
behavior and consequently, recording dopamine dynamics during the actual touchscreen tasks would be most
informative. Nonetheless, the observed opposing effect
on operant behaviors in our study is in line with recently
published work on behavioral flexibility.13 Specifically, we
previously found that mice with a loss of striatal VAChT
are more prone to habits whereas mice with a loss of striatal VGLUT3 favor goal-directed behavior.13
It should also be noted that both ACh and Glu directly
affect striatal function by mechanisms that are independent of dopamine, such as modulation of D1 and D2 medium spiny neurons (MSNs) directly26,61,62 and indirectly,
via the regulation of GABAergic interneurons.63,64 To
note, sequential responding has previously been associated with the activity of striatal MSNs, with these neurons signalling the initiation and termination of a specific
action sequence.56,65,66 Furthermore, Keeler et al. (2014)
found that pharmacologically activating or inhibiting
D2 signalling in wildtype rats impaired their ability to
complete a heterogenous sequence task. This suggests
that the D2 MSN pathway may drive response selection.30
Since VAChTcKO mice had a slowed overall performance
in the operant heterogenous sequence task (mimicking
controls treated with haloperidol), it is possible that these
mice have an altered D2 MSN pathway. In line with this
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idea, we found that treatment with the D2 antagonist,
haloperidol did not change the touchscreen performance
of VAChTcKO mice. In contrast, a loss of VGLUT3 from
CINs changed how haloperidol affected touchscreen performance. Specifically, VGLUT3cKO mice took 3 times as
long to complete the task. The reason for this distinction
in drug effect is likely that the VAChTcKO mice are as impaired in their D2 MSN pathway as they can be, and further blocking D2 receptors has little effect. Nonetheless, it
is possible that the effects reported herein are being partially mediated by D2 receptors on CINs themselves, instead of MSNs.67 By modulating CIN-mediated signalling
we could be interfering with their constitutive integrated
stress response, a biochemical process that influences
which proteins are synthesized in cholinergic striatal neurons.68 In particular, this integrated stress response is required for normal D2R-modulation of CINs and changes
in its functionality can affect the vigor of learned tasks.68
To evaluate if ACh and/or Glu are driving the observed
behavioral changes, we also investigated reward-evoked
dopamine release and reward-based learning in mice
where CINs are incapable of releasing both neurotransmitters effectively (DKO mice). When examining dopamine
signalling in the DKO mice, similar to VAChTcKO mice,
DKO mice have a lower dopamine peak in the nucleus accumbens shell. However, the overall dopamine release of
DKO mice is unchanged (area under the curve), owing to
a prolonged response which mimics VGLUT3cKO mice.
This finding suggests that ACh and Glu released by CIN
seem to have additive and independent effects.
In contrast to the single KO mice (VAChTcKO,
VGLUT3cKO), we found that DKO mice had more pronounced changes in performance in homogenous tasks
(FR/PR). Specifically, DKO mice were slower to learn the
initial tasks (FR1 task) but once they learned, they were
more willing to work compared to controls (PR4 and PR8).
However, this increased PR performance only manifested
after two training days in the task. These mutant mice were
also significantly impaired in the heterogenous sequence
task. In particular, the DKO mice showed an increased
level of responding, commonly on blank windows (often
the central window), leading to them to take twice as long
to complete the task when compared to their littermate
controls. Together the changed performance in the operant tasks may suggest that DKO mice have aberrant habitual behavior. This is consistent with studies that show that
ablation of CINs leads to deficits in behavioral flexibility
and increased compulsive behavior.69,70 Furthermore, this
result is in line with our previous study that indicates altering neurotransmitter release from CINs disrupts the
balance between goal directed and habitual behavior.13
However, to confirm that DKO mice are indeed habitual
future studies would require a devaluation paradigm to
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be performed. Additionally, we have to consider that the
enhanced nose-poking behavior could be impacted by
locomotion as DKO mice are hyperactive in a novel environment. Nonetheless, we see minimal changes in correct and reward response latencies in the operant tasks.
Furthermore, previous studies have shown that extensive
training in touchscreen tasks can diminish hyperactivity if
mice have intact habituation.36
Beyond the homogenous tasks, we consistently found
that the behavior of DKO mice is similar to VAChTcKO
mice: impaired in the heterogeneous sequence task and
unresponsive to haloperidol's slowing down affect. This
would suggest that ACh might be the predominant signalling molecule for driving the operant behavioral responses
studied here. However, it is likely that this relationship
is more complex and depends on the type of task and
individual motivation to perform a task. Furthermore,
it is likely that direct and indirect responses to ACh and
Glu released by CINs on striatal MSNs collaborate with
dopamine signalling to shape behavior. Interestingly, the
overall behavioral changes in DKO mice do not reflect
the additive influence of VAChT and VGLUT3 in dopamine release. Specifically, the dopamine release effects
of VAChT and VGLUT3 single deletions seem to be combined in DKO mice where both lower amplitude and prolonged dopamine response is apparent, yet their behavior
primarily reflects the VAChT deletion. This may suggest
that changes in dopamine signaling are not simply translated into behavior and other parameters (changes in ACh
and Glu release itself, compensational circuit alterations)
are contributing to the final behavioral phenotype.
Our study primarily focuses on the basal ganglia as
the striatum has been shown to regulate reward-based
learning.71,72 However, we have previously shown that
the D2-Cre driver leads to a 50% decrease of VAChT levels
in the cortex13 which could also contribute to the behavioral phenotype observed in VAChTcKO and DKO mice.
Nonetheless, the phenotypes of VAChTcKO mice are relatively mild in this study, indicating that the cortical VAChT
decrease itself does not induce major changes in the studied behavior. Only when VGLUT3 was also deleted (DKO
mice), presumably disrupting the function of striatal
CINs, mice responded more in the PR task and were significantly more impaired in the heterogeneous sequence
task. To separate the effect of striatal and cortical VAChT,
in future studies it would be ideal to target the deletion of
VAChT in the striatum of adult mice using viral vectors.
Notably, we have previously shown that virally targeting
VAChT in the DMS can recapitulate the impairments of
goal-directed learning evident in VAChTcKO mice.13 This
viral approach would also rule out the involvement of developmental compensatory mechanisms on the endophenotypes herein uncovered. As mutant mice are born with
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decreased cholinergic and/or glutamatergic tone in the
striatum, it is possible that compensatory changes may
have occurred since birth and behavioral effects of ACh
or Glu release are masked/modified. Nonetheless, even if
a portion of the phenotype can be associated with developmental changes, this study still speaks to the distinct
roles and contributions that two neurotransmitters have
in striatal-dependent behaviors.
In conclusion, the data provide novel information into
how the striatal network is regulated during behavior and
clarify the differential impact of CIN-released ACh and
Glu. It highlights the complexity that co-transmission
brings to neuronal signaling and functional regulation.
We found that ACh and Glu have opposing effects on operant responding which could be associated with changes
in dopamine signaling and/or D2 pathways. Notably, we
found that ACh release from CINs may drive the majority
of behavioral responses, whereas Glu release seems to be
mainly involved in refining behavioral outputs. Dual neurotransmitter neurons are found in multiple organisms, including flies, where they can regulate complex behaviors.73
VGLUTs have been suggested to facilitate the loading of
vesicles with ACh and other neuromodulators,25,74–76 albeit VGLUTs and other neurotransmitter transporters may
be segregated in different vesicles.77 Our results illustrate
potential reasons by which dual-transmitter neuronal systems could be favoured during evolution, beyond facilitating the release of one of the neurotransmitters. Neurons
that release two neurotransmitters are poised to regulate
a much wider repertoire of behavioral outcomes, likely by
activating a more diverse set of receptors. Ultimately, understanding how dual transmitter systems are modulated
in individual neurons and contribute to control behavior
will help to decode how neuronal communication impacts
neuronal representation of more sophisticated behavior
repertoires.
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